← Back to markets

Moderna

MRNA · Health Care · Biotechnology
$154.27
RS +214.2

Returns

7D-2.9%
1M+179.8%
3M+238.0%
6M+209.6%
YTD+423.1%
1Y+540.4%

About Moderna

Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".